515 filings
Page 11 of 26
4
Klompas Neil A
11 Dec 20
Zymeworks / Neil A Klompas ownership change
7:30pm
8-K
ZYME
Zymeworks BC Inc
10 Dec 20
Zanidatamab Clinical Data Selected for Oral Presentation at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
4:05pm
4
ZYME
Zymeworks BC Inc
9 Dec 20
Zymeworks / Ali Tehrani ownership change
7:35pm
4
Hausman Diana
4 Dec 20
Zymeworks / DIANA HAUSMAN ownership change
7:45pm
8-K
ZYME
Zymeworks BC Inc
4 Dec 20
Other Events
4:25pm
424B7
ZYME
Zymeworks BC Inc
4 Dec 20
Prospectus with selling stockholder info
4:23pm
4
Hausman Diana
3 Dec 20
Zymeworks / DIANA HAUSMAN ownership change
7:54pm
8-K
ZYME
Zymeworks BC Inc
2 Dec 20
Regulation FD Disclosure
4:05pm
8-K
ZYME
Zymeworks BC Inc
1 Dec 20
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration with BeiGene
4:10pm
8-K
ZYME
Zymeworks BC Inc
30 Nov 20
Zymeworks Receives FDA Breakthrough Therapy Designation for HER2-Targeted Bispecific Antibody Zanidatamab in Patients with Biliary Tract Cancer
4:06pm
4
O'Driscoll Kathryn
19 Nov 20
Zymeworks / Kathryn O'Driscoll ownership change
8:00pm
8-K
ZYME
Zymeworks BC Inc
19 Nov 20
Regulation FD Disclosure
4:17pm
8-K
ZYME
Zymeworks BC Inc
16 Nov 20
Regulation FD Disclosure
4:29pm
8-K
ZYME
Zymeworks BC Inc
10 Nov 20
Zymeworks to Present at Upcoming Investor Conferences
4:06pm
SC 13G/A
ZYME
Zymeworks BC Inc
10 Nov 20
Zymeworks / FMR ownership change
10:27am
4
Ali Tehrani
4 Nov 20
Zymeworks / Ali Tehrani ownership change
9:37pm
8-K
ZYME
Zymeworks BC Inc
3 Nov 20
Zymeworks Reports 2020 Third Quarter Financial Results
4:17pm
10-Q
2020 Q3
ZYME
Zymeworks BC Inc
Quarterly report
3 Nov 20
4:07pm
4
Hausman Diana
16 Sep 20
Zymeworks / DIANA HAUSMAN ownership change
5:03pm
8-K/A
ZYME
Zymeworks BC Inc
3 Sep 20
Zymeworks to Present at Upcoming Investor Conferences
4:05pm